{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:18:17Z","timestamp":1761405497911,"version":"build-2065373602"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010232","name":"National Institute of Development Administration","doi-asserted-by":"publisher","award":["R01DA17355","TAK-375 107"],"award-info":[{"award-number":["R01DA17355","TAK-375 107"]}],"id":[{"id":"10.13039\/501100010232","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.sleep.2018.06.003","type":"journal-article","created":{"date-parts":[[2018,6,26]],"date-time":"2018-06-26T17:47:39Z","timestamp":1530035259000},"page":"118-123","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["How representative are insomnia clinical trials?"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9237-0153","authenticated-orcid":false,"given":"T.","family":"Roehrs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Verster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Koshorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Withrow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Roth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2014","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","key":"10.1016\/j.sleep.2018.06.003_bib1"},{"year":"2014","series-title":"The international classification of sleep disorders","author":"American Academy of Sleep Medicine","key":"10.1016\/j.sleep.2018.06.003_bib2"},{"year":"2000","series-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","key":"10.1016\/j.sleep.2018.06.003_bib3"},{"year":"2010","series-title":"The international classification of sleep disorders","author":"American Academy of Sleep Medicine","key":"10.1016\/j.sleep.2018.06.003_bib4"},{"key":"10.1016\/j.sleep.2018.06.003_bib5","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.5665\/SLEEP.1230","article-title":"Insomnia and the performance of US workers: results from the America insomnia survey","volume":"34","author":"Kessler","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.06.003_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.smrv.2006.06.002","article-title":"Insomnia: pathophysiology and implications for treatment","volume":"11","author":"Roth","year":"2007","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.06.003_bib7","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.sleep.2015.06.015","article-title":"Durability of treatment response to zolpidem with three different maintenance regimeens: a preliminary study","volume":"16","author":"Perlis","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.06.003_bib8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.sleep.2006.04.008","article-title":"Efficacy and safety of zolpidem-MR: a double-blind, placebo-controlled study in adults with primary insomnia","volume":"7","author":"Roth","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.06.003_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/sleep\/31.1.79","article-title":"Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study","volume":"31","author":"Krystal","year":"2008","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.06.003_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.5665\/sleep.2370","article-title":"Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneious middle-of-the-night awakening in insomnia in a randomnized, double-blind, placebo-controlled out-patient study","volume":"36","author":"Roth","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.06.003_bib11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4088\/JCP.v60n0806","volume":"60","author":"Elie","year":"1999","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sleep.2018.06.003_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1093\/sleep\/33.2.225","article-title":"A\u00a012-week randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep\/wake function in older adults with primary and comorbid insomnia","volume":"33","author":"Ancoli-Israel","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.06.003_bib13","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/sleep\/26.7.793","article-title":"Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia","volume":"26","author":"Krystal","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.06.003_bib14","first-page":"1433","article-title":"Efficacy and safety of doxepin 3 and 6 mg in a 35-day sleep laboratory trial in adults with chronic primary insomnia","volume":"34","author":"Krystal","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.06.003_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.sleep.2011.09.006","article-title":"Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia","volume":"13","author":"Lankford","year":"2012","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.06.003_bib16","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4088\/JCP.07m03834","article-title":"Safety and subjective sleep effects of ramelteon administration in adults and older adults with chronic primary insomnia: a 1-year open label study","volume":"70","author":"Richardson","year":"2009","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.sleep.2018.06.003_bib17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.5665\/sleep\/32.3.351","article-title":"Efficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomnia","volume":"32","author":"Mayer","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.06.003_bib18","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.biopsych.2014.10.003","article-title":"Suvorexant in patients with insomnia: results from two 3-month randomized controlled clinical trials","volume":"79","author":"Herring","year":"2016","journal-title":"Bio Psychiat"},{"key":"10.1016\/j.sleep.2018.06.003_bib19","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia","volume":"79","author":"Herring","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2018.06.003_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.5664\/jcsm.4110","article-title":"A\u00a0randomized, double-blind, placebo-controlled, multicenter, 28-day polysomnographic study of gabapentin in transient insomnia induced by sleep phase advance","volume":"10","author":"Furey","year":"2014","journal-title":"JCSM"},{"key":"10.1016\/j.sleep.2018.06.003_bib21","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.sleep.2015.04.001","article-title":"Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a randomized, 6-week sleep laboratory trial","volume":"7","author":"Ivygy-May","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.06.003_bib22","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.sleep.2015.03.005","article-title":"Esmirtazapine in non-elderly adult patients with primary insomnia: efficacy and safety from a 2-week randomized outpatient trial","volume":"7","author":"Ivgy-May","year":"2015","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.06.003_bib23","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/7854_2014_324","article-title":"Physiological correlates of insomnia","volume":"21","author":"Roehrs","year":"2014","journal-title":"Curr Topics Behav Neurosci"},{"key":"10.1016\/j.sleep.2018.06.003_bib24","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.jpsychires.2006.07.008","article-title":"The association of insomnia with anxiety disorders and depression: exploration of the direction of risk","volume":"40","author":"Johnson","year":"2006","journal-title":"J\u00a0Psychiatry Res"},{"key":"10.1016\/j.sleep.2018.06.003_bib25","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.5665\/sleep.2208","article-title":"Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study","volume":"35","author":"Randall","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/j.sleep.2018.06.003_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.sleep.2016.06.008","article-title":"Hyperarousal in insomnia and hypnotic dose escalation","volume":"23","author":"Roehrs","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2018.06.003_bib27","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1177\/0269881111424455","article-title":"Twelve months of nightly zolpidem does not lead to rebound insomnia or withdrawal symptoms: a prospective placebo-controlled study","volume":"28","author":"Roehrs","year":"2012","journal-title":"Psychopharmacology"},{"year":"1968","series-title":"A\u00a0manual of standardized terminology, techniques, and scoring system for sleep stages of human subjects","author":"Rechtschaffen","key":"10.1016\/j.sleep.2018.06.003_bib28"},{"year":"2014","series-title":"The AASM manual for the scoring of sleep and associated events, Version 2.1","author":"American Academy of Sleep Medicine","key":"10.1016\/j.sleep.2018.06.003_bib29"},{"key":"10.1016\/j.sleep.2018.06.003_bib30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1097\/JCP.0b013e3181a390ba","article-title":"Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder","volume":"29","author":"Fava","year":"2009","journal-title":"J\u00a0Clin Psychopharm"},{"key":"10.1016\/j.sleep.2018.06.003_bib31","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/archpsyc.65.5.551","article-title":"Eszopiclone co-administered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder","volume":"65","author":"Pollack","year":"2008","journal-title":"Arch Gen Psychiat"},{"key":"10.1016\/j.sleep.2018.06.003_bib32","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/j.biopsych.2006.01.016","article-title":"Eszopiclone co-administered with fluoxetine in patients with insomnia co-existing with major depressive disorder","volume":"59","author":"Fava","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.sleep.2018.06.003_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.schres.2014.10.002","article-title":"The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a doubled-blind, randomized, placebo-controlled trial","volume":"160","author":"Tek","year":"2014","journal-title":"Schizo Res"},{"key":"10.1016\/j.sleep.2018.06.003_bib34","series-title":"Sleep and affect: assessment, theory, and clinical implications","first-page":"377","article-title":"Sleep and pain","author":"Roehrs","year":"2015"},{"key":"10.1016\/j.sleep.2018.06.003_bib35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.anclin.2016.01.007","article-title":"Patients with chronic pain","volume":"34","author":"Cheatie","year":"2016","journal-title":"Anesthesiology Clin"},{"key":"10.1016\/j.sleep.2018.06.003_bib36","first-page":"245","article-title":"Effects of triazolam on sleep, daytime sleepiness, and morning stiffness in patients with rheumatoid arthritis","volume":"23","author":"Walsh","year":"1996","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.sleep.2018.06.003_bib37","first-page":"292","article-title":"The effect of eszopiclone in patients with insomnia and coexisting rheumatoid arthritis: a pilot study","volume":"11","author":"Roth","year":"2009","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.sleep.2018.06.003_bib38","first-page":"529","article-title":"The effect of zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study","volume":"23","author":"Moldofsky","year":"1996","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.sleep.2018.06.003_bib39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","article-title":"Effect of pregablin in neuropathis pain evaluated in a 12-week, randomized, double-bline, multicenter, placebo-controlled trial of flexible- and fixed-dose regimens","volume":"115","author":"Freynhagen","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.sleep.2018.06.003_bib40","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of fibromyalgia syndrome. Results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.sleep.2018.06.003_bib41","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.psc.2015.07.008","article-title":"Sleep disturbance in substance use disorders","volume":"38","author":"Roehrs","year":"2015","journal-title":"Psychiat Clin N Am"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945718303010?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945718303010?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:14:16Z","timestamp":1761405256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945718303010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":41,"alternative-id":["S1389945718303010"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2018.06.003","relation":{},"ISSN":["1389-9457"],"issn-type":[{"type":"print","value":"1389-9457"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How representative are insomnia clinical trials?","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2018.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}